Total Payments
$7,278
2024 Payments
$932.19
Companies
38
Transactions
171
Medicare Patients
3,530
Medicare Billing
$577,272
Payment Breakdown by Category
Food & Beverage$4,352 (59.8%)
Gifts$2,859 (39.3%)
Education$66.61 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,352 | 168 | 59.8% |
| Gift | $2,859 | 1 | 39.3% |
| Education | $66.61 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,387 | 25 | $0 (2024) |
| Amgen Inc. | $371.98 | 8 | $0 (2022) |
| ABBVIE INC. | $339.22 | 24 | $0 (2024) |
| US WorldMeds, LLC | $296.20 | 15 | $0 (2020) |
| Kyowa Kirin, Inc. | $225.07 | 10 | $0 (2024) |
| UCB, Inc. | $217.18 | 6 | $0 (2024) |
| Boston Scientific Corporation | $205.68 | 3 | $0 (2020) |
| Neurelis, Inc. | $205.46 | 6 | $0 (2024) |
| SK Life Science, Inc. | $189.15 | 7 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $184.56 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $932.19 | 34 | Neurelis, Inc. ($110.84) |
| 2023 | $805.22 | 30 | UCB, Inc. ($107.63) |
| 2022 | $1,150 | 54 | ABBVIE INC. ($219.68) |
| 2021 | $60.05 | 4 | Allergan, Inc. ($28.11) |
| 2020 | $247.20 | 4 | Boston Scientific Corporation ($107.27) |
| 2019 | $412.53 | 19 | US WorldMeds, LLC ($169.29) |
| 2018 | $598.86 | 15 | Amgen Inc. ($222.86) |
| 2017 | $3,071 | 11 | Novartis Pharmaceuticals Corporation ($3,071) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $37.03 | General |
| Category: EPILEPSY | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/12/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/29/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Neurology | ||||||
| 10/22/2024 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $25.47 | General |
| Category: Diagnostic Tracer | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $29.11 | General |
| 10/01/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $14.66 | General |
| 09/10/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Adenosine A2A Receptors | ||||||
| 09/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.84 | General |
| Category: NEUROLOGY | ||||||
| 09/03/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $27.21 | General |
| 08/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Neurology | ||||||
| 08/14/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Neurology | ||||||
| 07/30/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: NEUROLOGY | ||||||
| 07/23/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: NEUROLOGY | ||||||
| 07/16/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Adenosine A2A Receptors | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: Neurology | ||||||
| 07/02/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $40.88 | General |
| Category: Neurology | ||||||
| 05/29/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Immunology | ||||||
| 05/21/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $36.78 | General |
| Category: EPILEPSY | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Neurology | ||||||
| 05/07/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: Immunology | ||||||
| 04/30/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $32.90 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 926 | 5,025 | $382,332 | $149,655 |
| 2022 | 12 | 929 | 12,978 | $512,843 | $157,654 |
| 2021 | 17 | 984 | 11,805 | $488,385 | $154,093 |
| 2020 | 9 | 691 | 5,750 | $389,178 | $115,869 |
Total Patients
3,530
Total Services
35,558
Medicare Billing
$577,272
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 261 | 505 | $158,064 | $66,474 | 42.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 143 | 143 | $55,610 | $23,317 | 41.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 14 | 3,600 | $45,000 | $16,561 | 36.8% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 45 | 52 | $28,811 | $11,973 | 41.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 45 | 77 | $13,774 | $6,234 | 45.3% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2023 | 15 | 15 | $11,370 | $5,439 | 47.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 139 | 209 | $12,712 | $5,044 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 55 | $12,990 | $4,952 | 38.1% |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2023 | 12 | 155 | $8,370 | $3,880 | 46.4% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 97 | 100 | $10,247 | $2,697 | 26.3% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2023 | 83 | 86 | $8,784 | $2,376 | 27.0% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2023 | 14 | 14 | $9,030 | $494.48 | 5.5% |
| 95870 | Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study | Facility | 2023 | 14 | 14 | $7,570 | $213.22 | 2.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 25 | 11,850 | $170,363 | $55,888 | 32.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 231 | 231 | $120,106 | $36,857 | 30.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 201 | 276 | $109,161 | $35,859 | 32.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 209 | 319 | $31,696 | $8,090 | 25.5% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 17 | 19 | $21,660 | $4,584 | 21.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 16 | 30 | $11,003 | $3,446 | 31.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 21 | 36 | $8,820 | $3,067 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 34 | $9,894 | $2,938 | 29.7% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2022 | 41 | 42 | $9,858 | $2,586 | 26.2% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2022 | 66 | 66 | $9,018 | $1,708 | 18.9% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2022 | 56 | 60 | $8,265 | $1,560 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 15 | $3,000 | $1,071 | 35.7% |
About Dr. Robert Price, M.D
Dr. Robert Price, M.D is a Electrodiagnostic Medicine healthcare provider based in San Luis Obispo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1003085192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Price, M.D has received a total of $7,278 in payments from pharmaceutical and medical device companies, with $932.19 received in 2024. These payments were reported across 171 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,352).
As a Medicare-enrolled provider, Price has provided services to 3,530 Medicare beneficiaries, totaling 35,558 services with total Medicare billing of $577,272. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Electrodiagnostic Medicine
- Other Specialties Neurology, Neurology
- Location San Luis Obispo, CA
- Active Since 02/22/2008
- Last Updated 03/11/2023
- Taxonomy Code 204R00000X
- Entity Type Individual
- NPI Number 1003085192
Products in Payments
- GILENYA (Drug) $3,071
- KESIMPTA (Drug) $240.99
- Xadago (Drug) $213.45
- VALTOCO (Drug) $205.46
- Nourianz (Drug) $179.65
- QULIPTA (Drug) $179.09
- AUSTEDO (Drug) $173.43
- NURTEC ODT (Drug) $170.93
- BOTOX (Biological) $165.54
- Aimovig (Biological) $149.12
- Briviact (Drug) $141.54
- NUPLAZID (Drug) $130.60
- GENERAL - DBS (Device) $107.27
- GENERAL DBS (Device) $98.41
- Infinity DBS Pulse Generators (Device) $91.53
- TREVO (Device) $82.36
- AIMOVIG (Biological) $74.71
- MYOBLOC (Biological) $71.55
- EPIDIOLEX (Drug) $70.29
- Ongentys (Drug) $65.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.